Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: Results from a pilot study within the national screening programme in England

Gut

Volumn 66, Issue 9, 2017, Pages 1631-1644

  Moss, Sue ^a   Mathews, Christopher ^a   Day, T J ^b   Smith, Steve ^c   Seaman, Helen E ^d   Snowball, Julia ^d   Halloran, Stephen P ^d,e  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b NATIONAL HEALTH SERVICE   (United Kingdom)

^c Midlands and North West NHS England Bowel Cancer Screening Programme Hub   (United Kingdom)

^d NHS Bowel Cancer Screening Southern Programme Hub   (United Kingdom)

^e UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Colorectal Cancer Screening; Colorectal Neoplasia; Epidemiology

Indexed keywords

ADENOMA; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; COLONOSCOPY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENGLAND; FECAL IMMUNOCHEMICAL TEST; FEMALE; FOLLOW UP; GUAIAC BASED FECAL OCCULT BLOOD TEST; HUMAN; INTERMETHOD COMPARISON; INTESTINE CANCER; MALE; OCCULT BLOOD TEST; PILOT STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; SCREENING TEST; COLORECTAL TUMOR; EARLY CANCER DIAGNOSIS; FECES; IMMUNOCHEMISTRY; MIDDLE AGED; OCCULT BLOOD; PATHOLOGY; PATIENT PARTICIPATION; PROCEDURES; STANDARDS; STATISTICS AND NUMERICAL DATA; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME;

GUAIAC; HEMOGLOBIN;

AGED; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; ENGLAND; FECES; FEMALE; GUAIAC; HEMOGLOBINS; HUMANS; IMMUNOCHEMISTRY; MALE; MIDDLE AGED; OCCULT BLOOD; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT PARTICIPATION; PILOT PROJECTS; QUALITY IMPROVEMENT;

EID: 84973370159     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2015-310691     Document Type: Article

References (38)

1. Mandel JS, Bond JH, Church TR, et al. For the Minnesota Colon Cancer Control Study. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71.
2. Kewenter J, Brevinge H, Engarås B, et al. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68, 308 subjects. Scand J Gastroenterol 1994;29:468-73.
3. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
4. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
5. Hewitson P, Glasziou P, Watson E, et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): An update. Am J Gastroenterol 2008;103:1541-9.
6. Logan RF, Patnick J, Nickerson C, et al. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut 2012;61:1439-46.
7. Lo SH, Waller J, Wardle J, et al. Comparing barriers to colorectal cancer screening with barriers to breast and cervical screening: A population-based survey of screening-age women in Great Britain. J Med Screen 2013;20: 73-9.
8. von Wagner C, Baio G, Raine R, et al. Inequalities in participation in an organized national colorectal cancer screening programme: Results from the first 2.6 million invitations in England. Int J Epidemiol 2011;40:712-18.
9. Palmer CK, Thomas MC, von Wagner C, et al. Reasons for non-uptake and subsequent participation in the NHS Bowel Cancer Screening Programme: A qualitative study. Br J Cancer 2014;110:1705-11.
10. Hall NJ, Rubin GP, Dobson C, et al. Attitudes and beliefs of non-participants in a population-based screening programme for colorectal cancer. Health Expect 2015;18:1645-57.
11. Carroll MR, Seaman HE, Halloran SP. Tests and investigations for colorectal cancer screening. Clin Biochem 2014;47:921-39.
12. Hughes K, Leggett B, Del Mar C, et al. Guaiac versus immunochemical tests: Faecal occult blood test screening for colorectal cancer in a rural community. Aust N Z J Public Health 2005;29:358-64.
13. van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82-90.
14. Hoffman RM, Steel S, Yee EF, et al. Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: A randomized, controlled trial. Prev Med 2010;50:297-9.
15. Hol L, van Leerdam ME, van Ballegooijen M, et al. Screening for colorectal cancer: Randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010;59:62-8.
16. Rabeneck L, Rumble RB, Thompson F, et al. Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening. Can J Gastroenterol 2012;26:131-47.
17. Vart G, Banzi R, Minozzi S. Comparing participation rates between immunochemical and guaiac faecal occult blood tests: A systematic review and meta-analysis. Prev Med 2012;55:87-92.
18. Steele RJ, McDonald PJ, Digby J, et al. Clinical outcomes using a faecal immunochemical test for haemoglobin as a first-line test in a national programme constrained by colonoscopy capacity. United European Gastroenterol J 2013;1:198-205.
19. Digby J, McDonald PJ, Strachan JA, et al. Use of a faecal immunochemical test narrows current gaps in uptake for sex, age and deprivation in a bowel cancer screening programme. J Med Screen 2013;20:80-5.
20. http://www.bowelcanceruk.org.uk/media-centre/latest-news/scotland-announcesnew-bowel-cancer-test/
21. http://www.cancerscreening.nhs.uk/bowel/publications/the-facts.html
22. Fraser CG, Allison JE, Halloran SP, et al. A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin. J Natl Cancer Inst 2012;104:810-14.
23. Cairns SR, Scholefield JH, Steele RJ, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010;59:666-89.
24. https://www.gov.uk/government/publications/english-indices-of-deprivation-2010
25. Moss SM, Campbell C, Melia J, et al. Performance measures in three rounds of the English bowel cancer screening pilot. Gut 2012;61:101-7.
26. Cole SR, Young GP, Byrne D, et al. Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner. J Med Screen 2002;9:147-52.
27. Hewitson P, Ward AM, Heneghan C, et al. Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: Results of a factorial randomised trial. Br J Cancer 2011;105:475-80.
28. Shankleman J, Massat NJ, Khagram L, et al. Evaluation of a service intervention to improve awareness and uptake of bowel cancer screening in ethnically-diverse areas. Br J Cancer 2014;111:1440-7.
29. Wardle J, von Wagner C, Kralj-Hans I, et al. Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): Four cluster-randomised controlled trials. Lancet 2016;387:751-9.
30. Cole SR, Gregory T, Whibley A, et al. Predictors of re-participation in faecal occult blood test-based screening for colorectal cancer. Asian Pac J Cancer Prev 2012;13:5989-94.
31. Lo SH, Halloran S, Snowball J, et al. Predictors of repeat participation in the NHS bowel cancer screening programme. Br J Cancer 2015;112:199-206.
32. Lo SH, Halloran S, Snowball J, et al. Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme. Gut 2015;64:282-91.
33. Hassan C, Giorgi Rossi P, Camilloni L, et al. Meta-analysis: Adherence to colorectal cancer screening and the detection rate for advanced neoplasia, according to the type of screening test. Aliment Pharmacol Ther 2012;36:929-40.
34. Levi Z, Birkenfeld S, Vilkin A, et al. A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study. Int J Cancer 2011;128: 2415-24.
35. Federici A, Giorgi RP, Borgia P, et al. The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: A cluster randomized controlled trial. J Med Screen 2005;12: 83-8.
36. Park DI, Ryu S, Kim YH, et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol 2010;105: 2017-25.
37. Auge JM, Pellise M, Escudero JM, et al. Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program. Gastroenterology 2014;147:628-36.e1.
38. van Turenhout ST, Oort FA, van der Hulst RW, et al. Prospective cross-sectional study on faecal immunochemical tests: Sex specific cut-off values to obtain equal sensitivity for colorectal cancer? BMC Gastroenterol 2014;14:217.